# ICATIBANT ACETATE
> **ANDA210118** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-07-15
## Drug
- **FDA Application Number:** ANDA210118
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ICATIBANT ACETATE
- **Generic name:** ICATIBANT
- **Active ingredients:** ICATIBANT ACETATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2019-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210118)
---
*MORVS · CC0 1.0*